Vishnu Modur

457 total citations
14 papers, 354 citations indexed

About

Vishnu Modur is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Vishnu Modur has authored 14 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Vishnu Modur's work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (4 papers) and Immune Cell Function and Interaction (3 papers). Vishnu Modur is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (4 papers) and Immune Cell Function and Interaction (3 papers). Vishnu Modur collaborates with scholars based in United States, Japan and Sweden. Vishnu Modur's co-authors include Aya Kobayashi, Kounosuke Watabe, Puspa R. Pandey, Hiroshi Okuda, Misako Watabe, Koji Fukuda, Shigeru Hirota, Sudha K. Pai, Fei Xing and Andrew Wilber and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Vishnu Modur

12 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vishnu Modur United States 7 219 148 103 72 65 14 354
Sonja E. Volker United States 4 308 1.4× 101 0.7× 58 0.6× 43 0.6× 107 1.6× 5 408
Yukio Yamano Japan 10 235 1.1× 110 0.7× 57 0.6× 35 0.5× 82 1.3× 17 343
Yutaro Otsuka Japan 10 203 0.9× 132 0.9× 62 0.6× 42 0.6× 78 1.2× 10 328
Manh Tien Tran Japan 10 299 1.4× 56 0.4× 48 0.5× 40 0.6× 118 1.8× 24 357
Guillaume Davidson France 9 217 1.0× 91 0.6× 47 0.5× 48 0.7× 65 1.0× 16 297
Kyusam Choi South Korea 7 223 1.0× 84 0.6× 45 0.4× 35 0.5× 77 1.2× 8 330
Hiroe Nakamura Japan 12 182 0.8× 124 0.8× 38 0.4× 74 1.0× 113 1.7× 29 365
Chunzhao Yu China 12 193 0.9× 117 0.8× 51 0.5× 35 0.5× 102 1.6× 30 337
Patrick P.S. Leung United States 4 234 1.1× 109 0.7× 166 1.6× 22 0.3× 82 1.3× 5 366
N Echeverry Switzerland 6 259 1.2× 39 0.3× 38 0.4× 82 1.1× 76 1.2× 6 347

Countries citing papers authored by Vishnu Modur

Since Specialization
Citations

This map shows the geographic impact of Vishnu Modur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishnu Modur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishnu Modur more than expected).

Fields of papers citing papers by Vishnu Modur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishnu Modur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishnu Modur. The network helps show where Vishnu Modur may publish in the future.

Co-authorship network of co-authors of Vishnu Modur

This figure shows the co-authorship network connecting the top 25 collaborators of Vishnu Modur. A scholar is included among the top collaborators of Vishnu Modur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishnu Modur. Vishnu Modur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Modur, Vishnu, et al.. (2024). Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors. BioMed Research International. 2024. 1–19. 1 indexed citations
2.
Modur, Vishnu, et al.. (2023). Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects. Cell Reports. 42(4). 112364–112364. 1 indexed citations
3.
Kalim, Khalid W., Jun‐Qi Yang, Mark Wunderlich, et al.. (2022). Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity. Journal for ImmunoTherapy of Cancer. 10(11). e004806–e004806. 15 indexed citations
4.
Kalim, Khalid W., Jun‐Qi Yang, Vishnu Modur, et al.. (2021). Graded RhoA GTPase Expression in Treg Cells Distinguishes Tumor Immunity From Autoimmunity. Frontiers in Immunology. 12. 726393–726393. 6 indexed citations
5.
Modur, Vishnu, et al.. (2019). Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion. OncoImmunology. 8(11). 1657374–1657374. 43 indexed citations
6.
Modur, Vishnu. (2019). Abstract B083: Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Cancer Immunology Research. 7(2_Supplement). B083–B083.
7.
Modur, Vishnu, Navneet Singh, Vakul Mohanty, et al.. (2018). Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Nature Communications. 9(1). 4410–4410. 17 indexed citations
8.
Modur, Vishnu, et al.. (2017). Characterization of immortalized human mammary epithelial cell line HMEC 2.6. Tumor Biology. 39(10). 3726134028–3726134028. 5 indexed citations
9.
10.
11.
Okuda, Hiroshi, Aya Kobayashi, Bo Xia, et al.. (2011). Hyaluronan Synthase HAS2 Promotes Tumor Progression in Bone by Stimulating the Interaction of Breast Cancer Stem–Like Cells with Macrophages and Stromal Cells. Cancer Research. 72(2). 537–547. 160 indexed citations
12.
Liu, Wen, Hiroshi Okuda, Aya Kobayashi, et al.. (2011). KAI1 Gene Is Engaged in NDRG1 Gene-mediated Metastasis Suppression through the ATF3-NFκB Complex in Human Prostate Cancer. Journal of Biological Chemistry. 286(21). 18949–18959. 76 indexed citations
13.
14.
Leitzel, Kim, Seth A. Ettenberg, Robert J. Walsh, et al.. (2007). Elevated serum M-CSF level predicts reduced survival in metastatic breast cancer patients. Journal of Clinical Oncology. 25(18_suppl). 10591–10591. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonja E. Volker Breakdown of academic impact, for papers by Yukio Yamano Breakdown of academic impact, for papers by Yutaro Otsuka Breakdown of academic impact, for papers by Manh Tien Tran Breakdown of academic impact, for papers by Guillaume Davidson Breakdown of academic impact, for papers by Kyusam Choi Breakdown of academic impact, for papers by Hiroe Nakamura Breakdown of academic impact, for papers by Chunzhao Yu Breakdown of academic impact, for papers by Patrick P.S. Leung Breakdown of academic impact, for papers by N Echeverry
Rankless by CCL
2026